CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
93.85
+0.20 (0.21%)
Aug 20, 2026, 10:03 AM EDT - Market open
CVS Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 412,645 | 399,834 | 370,656 | 356,623 | 321,629 | 290,912 | |
Revenue Growth | 7.37% | 7.87% | 3.94% | 10.88% | 10.56% | 8.59% |
Cost of Revenue | 356,340 | 346,705 | 321,408 | 303,345 | 267,965 | 239,991 |
Gross Profit | 56,305 | 53,129 | 49,248 | 53,278 | 53,664 | 50,921 |
Selling, General & Admin | 44,147 | 43,110 | 41,229 | 39,205 | 37,922 | 36,764 |
Operating Expenses | 44,147 | 43,110 | 41,229 | 39,205 | 37,922 | 36,764 |
Operating Income | 12,158 | 10,019 | 8,019 | 14,073 | 15,742 | 14,157 |
Interest Expense | -3,102 | -3,119 | -2,958 | -2,658 | -2,287 | -2,503 |
Interest & Investment Income | 2,441 | 2,233 | 2,153 | 1,153 | 838 | 1,199 |
Other Non Operating Income (Expenses) | 1 | -5 | -5 | -6 | -4 | -4 |
EBT Excluding Unusual Items | 11,498 | 9,128 | 7,209 | 12,562 | 14,289 | 12,849 |
Merger & Restructuring Charges | -149 | -210 | -1,452 | -1,040 | -117 | -1,490 |
Impairment of Goodwill | -5,725 | -5,725 | - | - | - | -431 |
Gain (Loss) on Sale of Assets | 483 | 483 | - | -349 | -2,533 | - |
Legal Settlements | -320 | -1,540 | -100 | - | -5,803 | - |
Other Unusual Items | - | - | 491 | - | - | -391 |
Pretax Income | 5,787 | 2,136 | 6,148 | 11,173 | 5,836 | 10,537 |
Income Tax Expense | 902 | 408 | 1,562 | 2,805 | 1,509 | 2,548 |
Earnings From Continuing Operations | 4,885 | 1,728 | 4,586 | 8,368 | 4,327 | 7,989 |
Net Income to Company | 4,885 | 1,728 | 4,586 | 8,368 | 4,327 | 7,989 |
Minority Interest in Earnings | 5 | 40 | 28 | -24 | -16 | 12 |
Net Income | 4,890 | 1,768 | 4,614 | 8,344 | 4,311 | 8,001 |
Net Income to Common | 4,890 | 1,768 | 4,614 | 8,344 | 4,311 | 8,001 |
Net Income Growth | 7.92% | -61.68% | -44.70% | 93.55% | -46.12% | 11.45% |
Shares Outstanding (Basic) | 1,273 | 1,267 | 1,259 | 1,285 | 1,312 | 1,319 |
Shares Outstanding (Diluted) | 1,279 | 1,271 | 1,262 | 1,290 | 1,323 | 1,329 |
Shares Change | 1.19% | 0.71% | -2.17% | -2.49% | -0.45% | 1.14% |
EPS (Basic) | 3.84 | 1.40 | 3.66 | 6.49 | 3.29 | 6.07 |
EPS (Diluted) | 3.82 | 1.39 | 3.66 | 6.47 | 3.26 | 6.02 |
EPS Growth | 6.30% | -62.02% | -43.43% | 98.47% | -45.85% | 10.19% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 11,758 | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 |
Free Cash Flow Per Share | 9.19 | 6.14 | 5.01 | 8.06 | 10.17 | 11.85 |
Dividend Per Share | 2.660 | 2.660 | 2.660 | 2.420 | 2.200 | 2.000 |
Dividend Growth | 0% | 0% | 9.92% | 10.00% | 10.00% | 0% |
Gross Margin | 13.64% | 13.29% | 13.29% | 14.94% | 16.68% | 17.50% |
Operating Margin | 2.95% | 2.51% | 2.16% | 3.95% | 4.89% | 4.87% |
Profit Margin | 1.19% | 0.44% | 1.24% | 2.34% | 1.34% | 2.75% |
Free Cash Flow Margin | 2.85% | 1.95% | 1.71% | 2.92% | 4.18% | 5.41% |
EBITDA | 16,680 | 14,625 | 12,616 | 18,439 | 19,966 | 18,643 |
EBITDA Margin | 4.04% | 3.66% | 3.40% | 5.17% | 6.21% | 6.41% |
D&A For EBITDA | 4,522 | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 |
EBIT | 12,158 | 10,019 | 8,019 | 14,073 | 15,742 | 14,157 |
EBIT Margin | 2.95% | 2.51% | 2.16% | 3.95% | 4.89% | 4.87% |
Effective Tax Rate | 15.59% | 19.10% | 25.41% | 25.11% | 25.86% | 24.18% |
Revenue as Reported | 415,086 | 402,067 | 372,809 | 357,776 | 322,467 | 292,111 |
Advertising Expenses | - | 970 | 989 | 985 | 745 | 707 |